The path of discovery of each therapeutic antibody is different. We focus on your antibody goals and work with you to achieve the ADCC/CDC enhancement goals. Whether you need expression optimization, recombinant protein production, antibody ADCC/CDC modification design, or cell line development, Creative Biolabs provides solutions to drive your research and accelerate your market. Elezanumab Biobetter https://adcc.creative-biolabs.....com/afucosylated-ant

Non-fucosylated Anti-Human RGMA Therapeutic Antibody, an ADCC-Enhanced Biobetter [Lot: CB20-PZ422] - Creative Biolabs

Non-fucosylated Anti-Human RGMA Therapeutic Antibody, an ADCC-Enhanced Biobetter [Lot: CB20-PZ422] is available from creative biolabs.